CX3CL1 and Alzheimer disease: CX3CL1, which is identified inhibiting the production of TNF-α, nitric oxide (NO), and superoxide in neuron-glial cell cultures [41], has been implicated as an endogenous neuronal modulator and may limit microgliosis in AD by reducing the inflammatory reaction [37, 42, 43].